Davina gets her info from medics so it's far better to source the actual medics rather than a 3rd hand account. Some of her info is also slightly inaccurate.
The Royal College of Gynaecologists did a survey around 2015 of all supplements etc and found no effective one that worked for all women.
The British Menopause Society has this to say...
thebms.org.uk/publications/consensus-statements/non-hormonal-based-treatments-menopausal-symptoms/
British Menopause Society
Summary consensus statement
Non-hormonal-based treatments for menopausal symptoms
Summary practice points
As clinicians we must be familiar with alternative therapies, to help inform and guide women as to which options are most likely to be beneficial to them.
Few complementary and alternative treatment options have proven evidence of effectiveness, but although many options do not stand up to scrutiny from a robust and evidence
based perspective there will be individual women who will benefit from some of these treatments.
Placebo effect is not inconsiderable and in menopausal studies will play a part in individual experience and reported benefits.
@Selok On CVD
thebms.org.uk/publications/consensus-statements/primary-prevention-of-coronary-heart-disease-in-women/
Primary prevention of coronary heart disease in women
Summary
Coronary heart disease (CHD) is a leading cause of death in women. Observational studies have consistently shown oestrogen to help prevent CHD in postmenopausal women.
The large randomized controlled Women’s Health Initiative (WHI) trial initially did not confirm these observational findings. However, further analyses of the WHI study as well as metaanalyses of randomised clinical trials of hormone replacement therapy (HRT) and of the observational Nurses’ Health Study have now found that the timing of onset of HRT use is important and that oestrogen may have an important protective role in CHD, particularly in women initiating treatment below age 60 years.
This consensus statement will examine the evidence regarding HRT and non-oestrogen therapies (lipid lowering agents, aspirin, antihypertensives, antidiabetic medications, SERMs) as well as diet, lifestyle and smoking cessation in the primary prevention of CHD in women.
Summary practice points
oestrogen may have a protective role in CHD prevention especially if initiated in women below age 60 years or within 10 years of onset of menopause
women with a premature menopause should take oestrogen to reduce the risk of CHD
lipid-lowering agents are probably beneficial in primary prevention
aspirin cannot be recommended for primary prevention of CHD, but may protect against stroke
treating hypertension reduces the risk of CHD
in diabetics, prevention of CHD is based on management of established cardiovascular risk factors through both lifestyle measures and pharmacotherapy
in metabolic syndrome, prevention of CHD is based on management of established cardiovascular risk factors through both lifestyle measures and pharmacotherapy
stopping smoking, reducing obesity, improving diet and undertaking regular exercise are key lifestyle measures